Skip to content
OpenCapital
Get started

Merck & Co. MRK EPS (Diluted)

EPS (Diluted) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.31+9.2%
Pfizer logo
PfizerPFE
$0.47-9.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$6.75-7.2%
Cytokinetics logo
CytokineticsCYTK
-$1.67-22.8%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$0.59+15.7%

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$309.84B+56.1%
Enterprise value$353.54B+56.5%
P/E34.7×+23.3×
P/S4.7×+1.6×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s EPS (diluted)?
Merck & Co. (MRK) reported EPS (diluted) of -$1.72 in Q1 2026.
How has Merck & Co.'s EPS (diluted) changed year-over-year?
Merck & Co.'s EPS (diluted) decreased by 185.6% year-over-year, from $2.01 to -$1.72.
What is the long-term trend for Merck & Co.'s EPS (diluted)?
Over 3 years (2021 to 2025), Merck & Co.'s EPS (diluted) has grown at a 12.4% compound annual growth rate (CAGR), from $5.14 to $7.29.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.